Multimorbidity is common and associated with adverse outcomes in heart failure (HF). However, its prognostic value across frailty states is uncertain, particularly whether comorbidities continue to stratify risk once frailty develops.
To evaluate whether frailty modifies the association of multimorbidity i...
V. Copeland, B. Fishman, S. Elimelech et al.· European Heart Journal· 0 citations
Frailty is a multidimensional syndrome of reduced physiologic reserve associated with adverse outcomes in heart failure (HF). Whether its underlying drivers and prognostic significance differ by age remains poorly understood.
To assess age-specific correlations of frailty, predictors of incident frailty, a...
V. Copeland, B. Fishman, S. Elimelech et al.· European Heart Journal· 0 citations
Left ventricular hypertrophy is a hallmark of adverse remodeling in heart failure (HF), yet commonly used echocardiographic measures provide limited insight into sex-specific risk. Interventricular septal (IVS) thickness is routinely measured, but its independent prognostic value and potential sex-related differe...
A. Kaplan, V. Copeland, R. Loutati et al.· European Heart Journal· 0 citations
BACKGROUND
Hypertension (HTN) is a common comorbidity in patients with heart failure with reduced ejection fraction (HFrEF), yet its prognostic significance remains complex.
OBJECTIVE
To evaluate the association between HTN and all-cause mortality in patients with HFrEF, stratified by ischemic and nonischemic etiolog...
Daniel Zango, V. Copeland, Y. Wasserstrum et al.· Journal of Hypertension· 0 citations
BACKGROUND
Cardiac involvement in systemic amyloid A (AA) amyloidosis is traditionally considered rare. Respectively, contemporary data describing cardiac characteristics of patients with systemic AA amyloidosis are scarce.
METHODS
All patients with a diagnosis of systemic amyloidosis were identified from electronic...
A. Fardman, Robert Negev, O. Kukuy et al.· International Journal of Car...· 0 citations
In patients with heart failure and advanced chronic kidney disease, CCBs use was associated with improved survival, supporting their potential role as a safe adjunctive therapy for blood pressure control in this high-risk population.
V. Copeland, A. Milwidsky, S. Elimeleh et al.· American Journal of Medicine· 0 citations
Frailty fundamentally attenuates risk in HF, while multimorbidity stratifies prognosis only when physiological reserve is preserved, while multimorbidity stratifies prognosis only when physiological reserve is preserved.
V. Copeland, Boris Fishman, S. Elimeleh et al.· Mayo Clinic proceedings· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.